Clinical Trial Update: The RETRAIN Trial (Phase 1)

View source ↗

Summary

This update reports the completion of the RETRAIN trial, a Phase 1 study evaluating a treatment for ischaemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischaemic Stroke

Snippet

Sponsor: Countess of Chester NHS Foundation Trust | Conditions: Ischaemic Stroke | Status: COMPLETED